Medical Monitor, Genzyme Corporation [clinicaltrials_resource:a37317b1d61c1b7de15a5d9064c62422]
Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL) [clinicaltrials:NCT00042341]Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients [clinicaltrials:NCT00042354]Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00044889]Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia [clinicaltrials:NCT00046683]A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors. [clinicaltrials:NCT00046696]Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00051701]A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II [clinicaltrials:NCT00051935]rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease) [clinicaltrials:NCT00053573]A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease [clinicaltrials:NCT00059280]Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease [clinicaltrials:NCT00074932]clinicaltrials:NCT00074958A Prospective, Observational Study in Patients With Late-Onset Pompe Disease [clinicaltrials:NCT00077662]Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL [clinicaltrials:NCT00077961]An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass [clinicaltrials:NCT00078026]clinicaltrials:NCT00081497A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection [clinicaltrials:NCT00089947]clinicaltrials:NCT00103610A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea [clinicaltrials:NCT00106509]Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies [clinicaltrials:NCT00113048]Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism [clinicaltrials:NCT00123461]Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors [clinicaltrials:NCT00125827]Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602 [clinicaltrials:NCT00125879]A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis [clinicaltrials:NCT00131300]A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip [clinicaltrials:NCT00131326]clinicaltrials:NCT00131352A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis [clinicaltrials:NCT00131768]Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee [clinicaltrials:NCT00139295]Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery [clinicaltrials:NCT00140608]clinicaltrials:NCT00144781clinicaltrials:NCT00146757clinicaltrials:NCT00146770clinicaltrials:NCT00158600Study of the Treatment of Articular Repair (STAR) [clinicaltrials:NCT00158613]clinicaltrials:NCT00196716Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration [clinicaltrials:NCT00196729]Study of Safety and Efficacy of RenagelĀ® Compared With Calcium Acetate in Patients With Peritoneal Dialysis [clinicaltrials:NCT00196755]A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea [clinicaltrials:NCT00196794]An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients. [clinicaltrials:NCT00235300]A Study of rhGAA in Patients With Late-Onset Pompe Disease [clinicaltrials:NCT00250939]clinicaltrials:NCT00258011
responsible party [clinicaltrials_vocabulary:responsible-party]
Medical Monitor, Genzyme Corporation [clinicaltrials_resource:a37317b1d61c1b7de15a5d9064c62422]
Bio2RDF identifier
a37317b1d61c1b7de15a5d9064c62422
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a37317b1d61c1b7de15a5d9064c62422
name title [clinicaltrials_vocabulary:name-title]
Medical Monitor
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:a37317b1d61c1b7de15a5d9064c62422
title
Medical Monitor, Genzyme Corporation
@en
type
label
Medical Monitor, Genzyme Corpo ...... 317b1d61c1b7de15a5d9064c62422]
@en